133 related articles for article (PubMed ID: 19878975)
1. Membrane binding and anticoagulant properties of protein S natural variants.
Baroni M; Pavani G; Marescotti D; Kaabache T; Borgel D; Gandrille S; Marchetti G; Legnani C; D'Angelo A; Pinotti M; Bernardi F
Thromb Res; 2010 Feb; 125(2):e33-9. PubMed ID: 19878975
[TBL] [Abstract][Full Text] [Related]
2. The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S.
van Wijnen M; Stam JG; van't Veer C; Meijers JC; Reitsma PH; Bertina RM; Bouma BN
Thromb Haemost; 1996 Sep; 76(3):397-403. PubMed ID: 8883277
[TBL] [Abstract][Full Text] [Related]
3. Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domain.
Borgel D; Gaussem P; Garbay C; Bachelot-Loza C; Kaabache T; Liu WQ; Brohard-Bohn B; Le Bonniec B; Aiach M; Gandrille S
Biochem J; 2001 Dec; 360(Pt 2):499-506. PubMed ID: 11716779
[TBL] [Abstract][Full Text] [Related]
4. Studies of the interaction between human protein S and human C4b-binding protein using deletion variants of recombinant human protein S.
Chang GT; Maas BH; Ploos van Amstel HK; Reitsma PH; Bertina RM; Bouma BN
Thromb Haemost; 1994 Apr; 71(4):461-7. PubMed ID: 8052964
[TBL] [Abstract][Full Text] [Related]
5. Characterization of dysfunctional protein S-Tokushima (K155-->E) in relation to the molecular interactions required for the regulation of blood coagulation.
Hayashi T; Nishioka J; Suzuki K
Pol J Pharmacol; 1996; 48(2):221-3. PubMed ID: 9112655
[TBL] [Abstract][Full Text] [Related]
6. Mouse recombinant protein C variants with enhanced membrane affinity and hyper-anticoagulant activity in mouse plasma.
Krisinger MJ; Guo LJ; Salvagno GL; Guidi GC; Lippi G; Dahlbäck B
FEBS J; 2009 Nov; 276(22):6586-602. PubMed ID: 19817854
[TBL] [Abstract][Full Text] [Related]
7. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
8. Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation.
Preston RJ; Villegas-Mendez A; Sun YH; Hermida J; Simioni P; Philippou H; Dahlbäck B; Lane DA
FEBS J; 2005 Jan; 272(1):97-108. PubMed ID: 15634335
[TBL] [Abstract][Full Text] [Related]
9. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.
Dahlbäck B
Thromb Haemost; 1991 Jul; 66(1):49-61. PubMed ID: 1833851
[TBL] [Abstract][Full Text] [Related]
10. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C.
Geng JP; Cheng CH; Castellino FJ
Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780
[TBL] [Abstract][Full Text] [Related]
11. Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function.
Baroni M; Mazzola G; Kaabache T; Borgel D; Gandrille S; Vigano' D'Angelo S; Marchetti G; di Iasio MG; Pinotti M; D'Angelo A; Bernardi F
J Thromb Haemost; 2006 Jan; 4(1):186-91. PubMed ID: 16409468
[TBL] [Abstract][Full Text] [Related]
12. The anticoagulant protein C pathway.
Dahlbäck B; Villoutreix BO
FEBS Lett; 2005 Jun; 579(15):3310-6. PubMed ID: 15943976
[TBL] [Abstract][Full Text] [Related]
13. Binding site for C4b-binding protein in vitamin K-dependent protein S fully contained in carboxy-terminal laminin-G-type repeats. A study using recombinant factor IX-protein S chimeras and surface plasmon resonance.
He X; Shen L; Malmborg AC; Smith KJ; Dahlback B; Linse S
Biochemistry; 1997 Mar; 36(12):3745-54. PubMed ID: 9132028
[TBL] [Abstract][Full Text] [Related]
14. Functional properties of the sex-hormone-binding globulin (SHBG)-like domain of the anticoagulant protein S.
Saposnik B; Borgel D; Aiach M; Gandrille S
Eur J Biochem; 2003 Feb; 270(3):545-55. PubMed ID: 12542704
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional model of the SHBG-like region of anticoagulant protein S: new structure-function insights.
Villoutreix BO; Dahlbäck B; Borgel D; Gandrille S; Muller YA
Proteins; 2001 May; 43(2):203-16. PubMed ID: 11276089
[TBL] [Abstract][Full Text] [Related]
16. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
[TBL] [Abstract][Full Text] [Related]
17. SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations.
Villoutreix BO; García de Frutos P; Lövenklev M; Linse S; Fernlund P; Dahlbäck B
Proteins; 1997 Dec; 29(4):478-91. PubMed ID: 9408945
[TBL] [Abstract][Full Text] [Related]
18. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
[TBL] [Abstract][Full Text] [Related]
19. Cardiolipin enhances protein C pathway anticoagulant activity.
Fernández JA; Kojima K; Petäjä J; Hackeng TM; Griffin JH
Blood Cells Mol Dis; 2000 Apr; 26(2):115-23. PubMed ID: 10753602
[TBL] [Abstract][Full Text] [Related]
20. [Congenital protein S deficiencies; diagnostic difficulties].
Guermazi S; Conard J
Pathol Biol (Paris); 2009 Sep; 57(6):483-7. PubMed ID: 18583066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
